Navigation Links
Summary Judgment Granted for SEROQUEL(R) Patent Litigation
Date:7/1/2008

ure, tachycardia, diaphoresis, and cardiac dysrhythmia). Additional signs may include elevated creatine phosphokinase, myoglobinuria (rhabdomyolysis), and acute renal failure. The management of NMS should include immediate discontinuation of antipsychotic drugs.

Leukopenia, neutropenia, and agranulocytosis (including fatal cases), have been reported temporally related to atypical antipsychotics, including SEROQUEL. Patients with a pre-existing low white blood cell (WBC) count or a history of drug induced leukopenia/neutropenia should have their complete blood count monitored frequently during the first few months of therapy. In these patients, SEROQUEL should be discontinued at the first sign of a decline in WBC absent other causative factors. Patients with neutropenia should be carefully monitored, and SEROQUEL should be discontinued in any patient if the absolute neutrophil count is < 1000/mm3.

Tardive dyskinesia (TD), a potentially irreversible syndrome of involuntary dyskinetic movements, may develop in patients treated with antipsychotic drugs. The risk of developing TD and the likelihood that it will become irreversible are believed to increase as the duration of treatment and total cumulative dose of antipsychotic drugs administered to the patient increase. TD may remit, partially or completely, if antipsychotic treatment is withdrawn. SEROQUEL should be prescribed in a manner that is most likely to minimize the occurrence of TD.

Warnings and Precautions also include the risk of orthostatic hypotension, cataracts, seizures, hyperlipidemia, and possibility of suicide attempts. Examination of the lens by methods adequate to detect cataract formation, such as slit lamp exam or other appropriately sensitive methods, is recommended at initiation of treatment or shortly thereafter, and at 6-month intervals during chronic treatment. The possibility of a suicide attempt is inherent in schizophrenia, and close supervision of high risk patients sho
'/>"/>

SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Caraco Pharmaceutical Laboratories Ltd. Wins Summary Judgment on Generic Ultracet(R)
2. Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation
3. Delay in Start of VNUS Patent Litigation and Court Ruling on Summary Judgment Motion
4. Summary Notice of Class Action in Re McKesson HBOC, Inc. Securities Litigation
5. Par Pharmaceutical Provides Summary of Analyst/Investor Day
6. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
7. Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
8. Exercising judgment: The psychology of fitness
9. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
10. St. Davids HealthCare Granted the States Top Honor for Quality and Performance Excellence
11. MonoSol Rx Granted US Patent for Thin Film Manufacturing Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... (PRWEB) May 21, 2013 Go Classy ... today that they have redesigned their website featuring ... beach, pool, hot tubs, bars and dining. The website, ... resort including sales and guest reviews, will now have ... Jamaica itself, including pages on culinary local recipes, flora ...
(Date:5/21/2013)... May 21, 2013 The American Diabetes ... people in the United States of America are affected ... at a great risk of developing peripheral neuropathy which ... lives. The ADA further goes on saying that the ... and around 2 million new cases are diagnosed every ...
(Date:5/21/2013)... (HealthDay News) -- Aggressive treatment for prostate cancer ... with underlying medical conditions, a new study finds. ... radiation and radioactive seed implants, can cause serious ... and bowel problems, explained researchers from the University ... found that older patients with slower growing forms ...
(Date:5/21/2013)... for research and economic development will urge congressional ... of supercomputers designed to tackle complex societal questions, ... Daniel Reed will appear at a hearing on ... Energy, titled, "America,s Next Generation Supercomputer: The Exascale ... Room 2318 of the Rayburn House Office Building ...
(Date:5/21/2013)... 21 (HealthDay News) -- When a classmate commits suicide, ... themselves, according to a new study. This "suicide contagion" ... student personally, the researchers found. Teens aged 12 ... by Dr. Ian Colman, Canada Research Chair in Mental ... of Public Health. The study appeared May 21 in ...
Breaking Medicine News(10 mins):Health News:The Oldest and Original Nudist Travel Agency for NResort Announced Today a Redesigned Website Featuring Information on Culinary Events, Flora and Fauna, and Photography 2Health News:Neuracel Aims to Reduce Peripheral Neuropathy Pain 2Health News:Age, Other Illnesses May Make Prostate Cancer Treatment Unnecessary 2Health News:Iowa VP for Research addresses next-generation supercomputers at congressional hearing 2Health News:Student Suicide May Spur Similar Thoughts in Teens 2
... During the course of a hospitalization, patients are ... to the physician who has primary responsibility for ... details, illegibility, lost paperwork or other problems may ... implemented. , An award-winning study by Martin Were, ...
... Palomar Medical Technologies, Inc. (Nasdaq: PMTI ... for cosmetic treatments, announced today that it will unveil ... Optic(TM), LuxPowR(TM) pulsed-light handpiece and a more powerful Aspire ... of the American Academy of Dermatology (AAD) in San ...
... and Management,s History of Over-Promising & Under-Delivering Bodes ... The LCA-Vision Full Value Committee announced today ... the stockholders of LCA-Vision, Inc.: March 6, 2009Dear ... LCAV, with over 11% of the stock, we ...
... already at the heart of many management and prevention ... of the ESC Council on Cardiovascular Nursing and Allied ... complex needs of people with heart disease. "Of course, ... Deaton, "and we have seen heart disease rates decrease. ...
... Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical ... its Executive Chairman and Chief Executive Officer Mr. ... (SRA) 5th Annual Winter Technology Conference on Monday, ... Technology Conference, Mr. MacLellan will provide details of ...
... PowerPath(R) AP LIS to Interface with BioImagene,s ... March 6 Impac Software, part of ... software solutions for anatomic pathology (AP) laboratories, ... solutions, today announced the development of an ...
Cached Medicine News:Health News:Giving doctors the complete picture 2Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 2Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 3Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 4Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 5Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 6Health News:The LCA-Vision Full Value Committee Urges LCA-Vision (NASDAQ: LCAV) Stockholders to Reject the Status Quo 2Health News:The LCA-Vision Full Value Committee Urges LCA-Vision (NASDAQ: LCAV) Stockholders to Reject the Status Quo 3Health News:The LCA-Vision Full Value Committee Urges LCA-Vision (NASDAQ: LCAV) Stockholders to Reject the Status Quo 4Health News:The LCA-Vision Full Value Committee Urges LCA-Vision (NASDAQ: LCAV) Stockholders to Reject the Status Quo 5Health News:Nurses and allied professionals at heart of cardiovascular prevention and management programs 2Health News:Nurses and allied professionals at heart of cardiovascular prevention and management programs 3Health News:AMDL, Inc. to Present at 5th Annual Winter Technology Conference Hosted by Security Research Associates, Inc. 2Health News:AMDL, Inc. to Present at 5th Annual Winter Technology Conference Hosted by Security Research Associates, Inc. 3Health News:Impac Software and BioImagene Develop Workflow Solution for Digital Pathology and the Laboratory Information Systems 2Health News:Impac Software and BioImagene Develop Workflow Solution for Digital Pathology and the Laboratory Information Systems 3
(Date:5/21/2013)... Calif. , May 21, 2013 ... and manufacture of wireless personal healthcare products and ... its reach, announcing the release of two new ... blood pressure monitors and scales: the Wireless Pulse ... (Photo: http://photos.prnewswire.com/prnh/20130521/SF17618 ) ...
(Date:5/21/2013)...  Lehigh Valley Health Network has announced the deployment ... to its existing arsenal of five 5-foot-5 germ-killing UV ... the network, LVHN is now deploying the largest fleet ... and provide the best possible patient care available. ... – the signature product of Memphis ...
(Date:5/21/2013)... VIEW, Calif. , May 21, 2013  Healthcare ... , Russia , ... (BRIC) are realizing there are no shortcuts.  This is ... in the United States.  Companies must change the dialogue ... value, customizing to local needs, and building regional partnerships ...
Breaking Medicine Technology:iHealth Lab adds new products and partners to mobile personal healthcare offering 2iHealth Lab adds new products and partners to mobile personal healthcare offering 3Lehigh Valley Expands Fleet of Superbug-Slaying Robots 2Lehigh Valley Expands Fleet of Superbug-Slaying Robots 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 2Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 4
... Calif. , Aug. 4 To combat the escalating ... New Momentum, the leading SaaS-based anti-counterfeiting solution.  Both companies expect that, ... violators, their New Momentum solution will play a key role in ... , , ...
... Cytel Inc., premier provider of adaptive clinical trial design services and software, recently ... studies based on frequentist or Bayesian methods. , ... The FDA,s recently issued adaptive trial guidelines draft encourages adaptive design ... , , ...
Cached Medicine Technology:Two More Global Pharmaceutical Companies Choose New Momentum to Stop Counterfeits 2Cytel Announces Compass® - The Only Professional Adaptive Trial Software Package for Bayesian or Frequentist Dose-Finding Studies 2Cytel Announces Compass® - The Only Professional Adaptive Trial Software Package for Bayesian or Frequentist Dose-Finding Studies 3
Disposable Microscissors: Horizontal, Curved...
Disposable Microscissors: Horizontal, Straight...
Disposable Microscissors: Vertical, 90...
Low profile, sharp-tipped scissors with a vertical cutting action. Excellent for peeling and cutting fine epiretinal membranes....
Medicine Products: